Animal Pharm is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By



Set Alert for MandA

Pestell in double animal nutrition acquisition of Pro-Ag, Verus

Pestell Group has acquired Pro-Ag Products and Verus Animal Nutrition through its Pestell Minerals & Ingredients (PMI) unit for an undisclosed fee.

Feed & Additives M&A

Elanco's purchase of Bayer could be just around the corner

Ongoing media rumors have suggested Elanco's plan to purchase Bayer Animal Health could be executed next week.

M&A Bayer Animal Health

Phibro expands nutritional potential with acquisition of microbial developer Osprey

Phibro Animal Health has acquired microbial products specialist Osprey Biotechnics for an undisclosed fee.

Phibro Animal Health Feed & Additives

Elanco continues to purchase partners with $60m deal for Prevtec Microbia

Elanco has significantly bolstered its swine vaccine portfolio by acquiring Canadian company Prevtec Microbia.

Elanco Prevtec Microbia

Zoetis to enter equine nutrition through US acquisition

Zoetis is to purchase Platinum Performance – a Californian family-owned firm focused on nutrition for dogs, cats and horses.

Zoetis Companion Animals

Piedmont divests fly control product for companion animal focus

Piedmont Animal Health has sold its Flynexx fly control brand to an affiliate of Japan's Sumitomo Chemical.

M&A Food Animals

Elanco acquisition bid accepted by Aratana shareholders

A strong majority of shareholders in Aratana Therapeutics have voted to accept the proposed bid for the company by Elanco.

Aratana Therapeutics Elanco

CombiGene closer to acquisition of Panion Animal Health

Sweden's CombiGene has moved a step closer to purchasing pet gene therapy specialist Panion Animal Health. 

M&A Deals

Where do human pharma's remaining animal health divestments lie?

More pharma companies are exiting the animal health space. With animal health becoming an increasingly independent sector, Animal Pharm editor Joseph Harvey looks at the remaining pharma businesses that still hold an interest in veterinary medicine. 

M&A Investments

Does Elanco have an appetite for Bayer's animal health business?

The latest rumor regarding the future of Bayer Animal Health has suggested Elanco could be poised to make a bid.

Elanco Bayer Animal Health

Dechra ups investment in pain mitigation expert Medical Ethics

Dechra Pharmaceuticals has acquired an extra 15% stake in Australian firm Medical Ethics for Aus$13.5 million ($9.5 million).

Dechra Pharmaceuticals M&A

Ceva nears portfolio equilibrium as IDT Biologika deal closes

Ceva Santé Animale's finalized acquisition of IDT Biologika's animal health assets has helped the firm move closer to having an evenly balanced product portfolio.

Ceva Sante Animale M&A